These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 31837960)
21. Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders. Dregan A; Chowienczyk P; Molokhia M Heart; 2017 Dec; 103(23):1867-1873. PubMed ID: 28601812 [TBL] [Abstract][Full Text] [Related]
22. Cardiometabolic Disorders in Psoriatic Disease. Sobchak C; Eder L Curr Rheumatol Rep; 2017 Aug; 19(10):63. PubMed ID: 28844116 [TBL] [Abstract][Full Text] [Related]
23. Psoriasis and cardiovascular disorders. Frieder J; Ryan C G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099 [TBL] [Abstract][Full Text] [Related]
24. Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications. Wang J; Wang YM; Ahn HY AAPS J; 2014 Sep; 16(5):938-47. PubMed ID: 24993574 [TBL] [Abstract][Full Text] [Related]
25. Lipoprotein Metabolism and Inflammation in Patients With Psoriasis. Armstrong EJ; Krueger JG Am J Cardiol; 2016 Aug; 118(4):603-9. PubMed ID: 27392508 [TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis. Lima Ede A; Lima MM; Marques CD; Duarte AL; Pita Ida R; Pita MG An Bras Dermatol; 2013; 88(6):1029-35. PubMed ID: 24474126 [TBL] [Abstract][Full Text] [Related]
34. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment. Hu SC; Lan CE Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479 [TBL] [Abstract][Full Text] [Related]